Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/21717
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMathei, Catharina-
dc.contributor.authorBourgeois, Stefan-
dc.contributor.authorBrixko, Christian-
dc.contributor.authorBlach, Sarah-
dc.contributor.authorMulkay, Jean-Pierre-
dc.contributor.authorRazavi, Homie-
dc.contributor.authorSerste, Thomas-
dc.contributor.authorROBAEYS, Geert-
dc.date.accessioned2016-07-12T12:44:25Z-
dc.date.available2016-07-12T12:44:25Z-
dc.date.issued2015-
dc.identifier.citationHEPATOLOGY, 62 (1), p. 1106A-1107A-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/1942/21717-
dc.language.isoen-
dc.publisherWILEY-BLACKWELL-
dc.titleThe modeled impact of improved Hepatitis C Virus (HCV) treatment strategies on HCV prevalence among people who inject drugs (PWIDs) in Belgium-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateNOV 13-17, 2015-
local.bibliographicCitation.conferencename66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)-
local.bibliographicCitation.conferenceplaceSan Francisco, CA-
dc.identifier.epage1107A-
dc.identifier.issue1-
dc.identifier.spage1106A-
dc.identifier.volume62-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notes[Mathei, Catharina] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Publ Hlth & Primary Care, Leuven, Belgium. [Bourgeois, Stefan] ZNA Campus Stuivenberg, Antwerp, Belgium. [Brixko, Christian] CHR Citadelle, Dept Gatroenterol & Digest Oncol, Liege, Belgium. [Blach, Sarah; Razavi, Homie] Ctr Dis Anal, Louisville, CO USA. [Mulkay, Jean-Pierre; Serste, Thomas] CHU St Pierre, Hepatogastroenterol, Brussels, Belgium. [Serste, Thomas] Univ Libre Bruxelles, Liver Unit, Dept Gastroenterol & Hepatopancreatol, CUB Hop Erasme, Brussels, Belgium. [Robaeys, Geert] Ziekenhuis Oost Limburg, Dept Gastroenterol & Hepatol, Genk, Belgium. [Robaeys, Geert] Hasselt Univ, Fac Med & Life Sci, Diepenbeek, Belgium.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000368375404088-
item.fullcitationMathei, Catharina; Bourgeois, Stefan; Brixko, Christian; Blach, Sarah; Mulkay, Jean-Pierre; Razavi, Homie; Serste, Thomas & ROBAEYS, Geert (2015) The modeled impact of improved Hepatitis C Virus (HCV) treatment strategies on HCV prevalence among people who inject drugs (PWIDs) in Belgium. In: HEPATOLOGY, 62 (1), p. 1106A-1107A.-
item.contributorMathei, Catharina-
item.contributorBourgeois, Stefan-
item.contributorBrixko, Christian-
item.contributorBlach, Sarah-
item.contributorMulkay, Jean-Pierre-
item.contributorRazavi, Homie-
item.contributorSerste, Thomas-
item.contributorROBAEYS, Geert-
item.accessRightsRestricted Access-
item.fulltextWith Fulltext-
crisitem.journal.issn0270-9139-
crisitem.journal.eissn1527-3350-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
2015-Hepatology (1).pdf
  Restricted Access		Published version87.46 kBAdobe PDFView/Open    Request a copy
Show simple item record

Page view(s)

10
checked on Jun 22, 2022

Download(s)

6
checked on Jun 22, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.